Hostname: page-component-77c89778f8-cnmwb Total loading time: 0 Render date: 2024-07-18T15:42:19.140Z Has data issue: false hasContentIssue false

Environmentally controlled sample stage for Scintag's six-position XRD sample changer

Published online by Cambridge University Press:  10 January 2013

Charles Buckner
Affiliation:
Advanced Design and Automation, Glaxo Wellcome, Inc., Five Moore Drive, PO Box 13398, Research Triangle Park, North Carolina 27709
Christopher Kidd
Affiliation:
Analytical Sciences, Glaxo Wellcome, Inc., Five Moore Drive, PO Box 13398, Research Triangle Park, North Carolina 27709
Stacey Long
Affiliation:
Pharmaceutics and Chemical Analysis, Glaxo Wellcome, Inc., Five Moore Drive, P.O. Box 13398, Research Triangle Park, North Carolina 27709
Peter Varlashkin
Affiliation:
Pharmaceutics and Chemical Analysis, Glaxo Wellcome, Inc., Five Moore Drive, P.O. Box 13398, Research Triangle Park, North Carolina 27709
Jim Zhu
Affiliation:
Pharmaceutics and Chemical Analysis, Glaxo Wellcome, Inc., Five Moore Drive, P.O. Box 13398, Research Triangle Park, North Carolina 27709

Abstract

An environmentally controlled sample stage for Scintag's six-position XRD sample changer is described. Unlike the commercial environmental stages for Scintag XRD units which require removal of the sample changer, and installation and alignment of the sample stage, the stage described herein is designed to fit directly on the sample changer with no realignment. Such a stage provides for more convenient operation for an X-ray diffractometer with multiple users in both routine (ambient environment) and nonroutine (nonambient temperatures up to 250 °C and varying relative humidities) modes. In addition, the new stage uses a window made of a material that is safer to machine compared to beryllium (which is toxic).

Type
Research Article
Copyright
Copyright © Cambridge University Press 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Byrn, S. R. (1982). Solid State Chemistry of Drugs (Academic, New York), pp. 3–27.Google Scholar
Kristl, A., Srčič, S., Vrečer, F., Šuštar, B., and Vojnovic, D. (1996). “Polymorphism and pseudopolymorphism: influencing the dissolution properties of the guanine derivative acyclovir,” Int. J. Pharm. 139, 231235.CrossRefGoogle Scholar
Rink, W. J., Mathias, H. G., and Schlenoff, J. B. (1994). “Hermetic sample housing for X-ray diffraction studies,” J. Appl. Crystallogr. 27, 666668.CrossRefGoogle Scholar